In vitro and in vivo opioid activity of [DPro6]dermorphin, a new dermorphin analogue

Peptides

Volumn 24, Issue 3, 2003, Pages 419-428

  Broccardo, M ^a   Usenko, A B ^b   Uranova, M G ^b   Guzevatykh, L S ^b   Kamensky, A A ^c   Andreeva, L A ^c   Alfeeva, L Y ^c   Myasoedov, N F ^c   Giannini, E ^a   Improta, G ^a   Emel'yanova, T G ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SEMENOV INSTITUTE OF CHEMICAL PHYSICS   (Russian Federation)

^c INSTITUTE OF MOLECULAR GENETICS   (Russian Federation)

Author keywords

In vitro and in vivo opioid activity; Peripheral administration; Rats; DPro6 dermorphin

Indexed keywords

CHARCOAL; DERMORPHIN; DERMORPHIN DERIVATIVE; DERMORPHIN[6 DEXTRO PROLINE]; ENZYME; MU OPIATE RECEPTOR; NALOXONE; OPIATE; PEPTIDE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLON; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG STRUCTURE; ENVIRONMENTAL TEMPERATURE; ENZYME DEGRADATION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; GUINEA PIG; HEART RATE; ILEUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MOTILITY; MALE; MAXIMUM PERMISSIBLE DOSE; MEAL; MOLECULE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; THERMOREGULATION; VAS DEFERENS;

CAVIA PORCELLUS; SUS SCROFA;

EID: 12444278570     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(03)00057-3     Document Type: Article

References (34)

1. Betbeder D., Sperandio S., Latapie J.P., de Nadai J., Etienne A., Zajac J.M.et al. Biovector nanoparticles improve antinociceptive efficacy of nasal morphine. Pharm. Res. 17(6):2000;743-748.
2. 2) to the rat brain: toxicokinetics investigations in a unilateral nasal occlusion model Toxicol. Appl. Pharmacol. 169(3):2000;238-248.
3. Broccardo M., Improta G., Nargi M., Melchiorri P. Effects of dermorphin on gastrointestinal transit in rats. Regul. Pept. 4:1982;91-96.
4. D'Amour F.E., Smith D.L. Method of determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
5. De Castiglione R., Rossi A.C. Structure-activity relationships of dermorphin synthetic analogues. Peptides. 6:1985;117-125.
6. Emel'yanova T.G., Usenko A.B., Deigin V.I., Yarova E.P., Kamensky A.A. Effect of dermorphin on thermoregulation in rats at selected ambient temperatures. Peptides. 17(2):1996;241-245.
7. Ferre J.P., Du C.h., Soldani G., Ruckenbush V. Peripheral versus central components of the effects of dermorphin on intestinal motility in fed rats. Regul. Pept. 13:1986;109-117.
8. Feuerestein G., Zukowska G.Z. Effect of dermorphin and morphine on the sympathetic and cardiovascular system in pithed rats. Neuropeptides. 9:1987;139-150.
9. 2 sites in the guinea pig ileum. Neurosci. Lett. 39:1983;51-56.
10. Hart JS. Rodents. In: Comparative physiology of the thermoregulation, vol. 2. New York: Academic Press; 1971. p. 1-149.
11. 2 and delta opioid receptor agonists on gastric functions in the rat. Neuropharmacology. 33:1994;977-981.
12. Jacoby H.I., Lopez I. A method for the evaluation of colonic propulsive motility in the mouse after i.c.v. administered compounds. Dig. Dis. Sci. 29:1984;551-556.
13. Kao H.D., Traboulsi A., Itoh S., Dittert L., Hussain A. Enhancement of the systemic and CNS specific delivery of L-dopa by the nasal administration of its water soluble prodrugs. Pharm. Res. 17(8):2000;978-984.
14. Malfroy B., Schwartz J.C. Properties of enkephalinase from rat kidney: comparison of dipeptidyl-carboxypeptidase and endopeptidase activities. Biochem. Biophys. Res. Commun. 106:1982;276-285.
15. Melchiorri P., Negri L. The dermorphin peptide family-review. Gen. Pharmacol. 27(7):1996;1099-1107.
16. Mignogna G., Severini C., Simmaco M., Negri L., Falconieri Erspamer G., Kreil G.et al. Identification and characterization of two dermorphins from skin extracts of the Amazonian frog Phyllomedusa bicolor. FEBS. 302:1992;151-154.
17. Montecucchi P.C., de Castiglione R., Piani S., Gozzini L., Erspamer V. Amino acid composition and sequence of dermorphin, a novel opiate-like peptide from the skin extracts of Phyllomedusa sauvagei. Int. J. Pept. Prot. Res. 17:1981;275-279.
18. Moren F. Doses forms and formulations for drug administration to the respiratory tract. Drug Dev. Ind. Pharm. 13:1987;695-728.
19. Negri L., Potenza R.L., Corsi R., Melchiorri P. Evidence for two subtypes of opioid receptors in rat brain. Eur. J. Pharmacol. 196:1991;335-336.
20. Negri L., Falconieri Erspamer G., Severini C., Potenza R.L., Melchiorri P., Erspamer V. Dermorphin related peptides and their amidated analogs activate two mu-opioid receptor subtypes that modulate antinociceptive and catalepsy in the rat. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7203-7207.
21. Negri L. Amphibian opioids: novel dermorphin-like peptides. In: Moody TW, editor. Growth factors, peptides and receptors. New York: Plenum Press; 1993. p. 51-60.
22. 7]dermorphin, a naturally occurring peptide with high affinity for μ-opioid receptors. Br. J. Pharmacol. 114:1995;57-66.
23. Negri L., Lattanzi R., Tabacco F., Scolaro B., Rocchi R. Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration. Br. J. Pharmacol. 124(7):1998;1516-1522.
24. 7]dermorphin in awake rats. Br. J. Pharmacol. 124:1998;345-355.
25. 2-receptor-mediated regulation of heart-rate in the conscious rat. Neuropharmacology. 31:1992;777-782.
26. Pattabirama N., Sorensen K.R., Langridge R., Bhatnagar R.S., Renugopalakrishnan V., Rapaka R.S. Molecular mechanics studies of dermorphin. Biochem. Biophys. Res. Commun. 140(1):1986;342-349.
27. Portolano F., Filippelli A., Marazzo R., Susanna V., Russo S., Stella L.et al. Cardiovascular and respiratory effects of dermorphin in rats. Res. Commun. Clin. Pathol. Pharmacol. 71:1991;131-152.
28. Raffa R.B., Mathiasen J.R., Jacoby H.I. Colonic bead expulsion time in normal and mu-opioid receptor deficient (CXBK) mice following central administration of mu- and delta agonists. Life Sci. 41:1987;2229-2234.
29. Riand J., Baron D., Nicolas P., Benajiba A., Teng Y., Naim M. The delta-selective opioid peptide dermenkephalin and the mu-selective hybrid peptide dermenkephalin-[1-4]-dermorphin-[5-7] display strikingly different conformations despite identical tetrapeptide N-termini/ a quantitative 2-D NMR and molecular modeling analysis. J. Biomol. Struct. Dyn. 17(3):1999;445-460.
30. Richter K., Egger R., Corsi R., Severini C., Kreil G. c-DNA encoding (D-Ala2)-deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphine-related opioid peptides. Proc. Natl. Acad. Sci. U.S.A. 87:1990;4836-4839.
31. Schulz R., Wuster M., Herz A. Centrally and peripherally mediated inhibition of intestinal motility by opioids. N.S. Arch. Pharmacol. 308:1979;255-260.
32. Tallarida RJ, Murray RB. Manual of pharmacological calculation. 2nd ed. New York: Springer-Verlag; 1986.
33. Tancredi T., Temussi P., Picone D., Amodeo P., Tomatis R., Salvadori S.et al. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues. Biopolymers. 31(6):1991;751-760.
34. Ugwoke M.I., Verbeke N., Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J. Pharm. Pharmacol. 53(1):2001;3-21.